Aerovent
Aerovent contains Ipratropium Bromide, which is an anticholinergic bronchodilator. It helps open up the airways in the lungs, making breathing easier for patients suffering from respiratory diseases like asthma and COPD.
Dosage by Body Weight
Inhalation use only. Dosage must be individualized. For MDIs (Metered Dose Inhalers), the usual adult dose is 1-2 inhalations three to four times daily. For nebulisation, the usual dose is 250-500 mcg up to four times daily.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy in infants below 5 kg have not been established.
- Body Weight
- 5-7 kg
- Dose
- 125 mcg (nebulised)
- Frequency
- As directed by physician
- Tracking Notes
- Must be administered under strict medical supervision, typically in a hospital setting.
- Body Weight
- 8-10 kg
- Dose
- 125 mcg (nebulised)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Administer via a nebuliser. Dilute with sterile normal saline if required.
- Body Weight
- 11-15 kg
- Dose
- 125 mcg to 250 mcg (nebulised)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Use with a face mask or mouthpiece as appropriate for child's age.
- Body Weight
- 16-20 kg
- Dose
- 250 mcg (nebulised) or 1 puff (via spacer)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Using a spacer with a metered-dose inhaler helps ensure correct delivery of the medicine.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Use only if prescribed | Safety and efficacy in infants below 5 kg have not been established. |
| 5-7 kg | 125 mcg (nebulised) | As directed by physician | Must be administered under strict medical supervision, typically in a hospital setting. |
| 8-10 kg | 125 mcg (nebulised) | 3 to 4 times daily | Administer via a nebuliser. Dilute with sterile normal saline if required. |
| 11-15 kg | 125 mcg to 250 mcg (nebulised) | 3 to 4 times daily | Use with a face mask or mouthpiece as appropriate for child's age. |
| 16-20 kg | 250 mcg (nebulised) or 1 puff (via spacer) | 3 to 4 times daily | Using a spacer with a metered-dose inhaler helps ensure correct delivery of the medicine. |
Formulation
Purpose
Used for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and as an add-on therapy in acute asthma exacerbations.
Generic Name
Ipratropium BromideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.